Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- ‘Don’t shy away’ from JAKs in IBD: Monitor patient outcomes, understand potential risks Kate Burba
-
- JAK inhibitors: ‘A valuable addition’ to the IBD treatment portfolio Edward V. Loftus Jr., MD
- ACG, ASGE update quality indicators for ‘delivery of high-quality’ GI endoscopy Kate Burba
- FDA approves Gilead’s Livdelzi for treatment of primary biliary cholangitis
- Intermittent fasting bests standard diet in lowering liver fat content in MASLD, obesity Kate Burba
- Mass screening for celiac disease in children ‘highly cost effective’ vs. standard care Kate Burba
- New ACG, ASGE quality indicators for colonoscopy include 3 key updates Kate Burba
- ‘No strong evidence’ to support discontinuation of GLP-1RAs prior to upper endoscopy Kate Burba
- Q&A: AGA snubs UHC’s choice to ‘forgo transparency’ in Gold Card program for GI endoscopy Monica Stonehill; Maria T. Abreu, MD
-
- Skyrizi outperforms Stelara in endoscopic remission at week 48 in Crohn’s disease Kate Burba